| Meridian Illinois Medicaid Clinical | Infigratinib (Truseltiq) (CP.PHAR.547) | |
| Meridian Illinois Medicaid Clinical | Ixekizumab | |
| Meridian Illinois Medicaid Clinical | Melphalan flufenamide (Pepaxto) (CP.PHAR.535) | |
| Meridian Illinois Medicaid Clinical | Moxetumomab pasudotox-tdfk (Lumoxiti) (CP.PHAR.398) | |
| Meridian Illinois Medicaid Clinical | Panobinostat (Farydak) (CP.PHAR.382) | |
| Meridian Illinois Medicaid Clinical | Umbralisib (Ukoniq) (CP.PHAR.531) | |
| Meridian Illinois Medicaid Clinical | Vincristine Sulfate Liposome Injection (Marqibo) (CP.PHAR.315) | |
| Meridian Illinois Medicaid Clinical | Cost to Charge Adjustments on Clean Claim Reviews (CC.PI.06) | |
| Meridian Illinois Medicaid Clinical | Concert Laboratory Payment Policy | |
| Meridian Michigan Medicaid Clinical | CG.CC.PP.01 Concert Laboratory Payment Policy | |